New Therapy First to Target Type 1 Diabetes Disease Process
New Therapy First to Target Type 1 Diabetes Disease Process A Barbara Davis Center for Diabetes patient became the first person in Colorado to receive a newly approved drug aimed at delaying onset of clinical stage type